代谢性超重/肥胖表型与慢性心力衰竭患者死亡风险之间的关联
You Zhou1, Yingli Xie2, Jingjing Dong2
1School of Medicine, Nankai University, Tianjin, China.
Frontiers in endocrinology
|October 7, 2024
概括
代谢综合征在男性和老年女性中增加心力衰竭死亡风险,而超重/肥胖在年轻女性中具有保护作用. 这些代谢因素与基于性别和年龄的慢性心力衰竭预后有不同的相互作用.
科学领域:
- 心脏病学 心脏病学
- 代谢障碍 代谢障碍 代谢障碍
- 肥胖问题研究研究
背景情况:
- 代谢障碍和肥胖在慢性心力衰竭 (CHF) 中很常见.
- 考虑到年龄和性别,这些疾病对心血管疾病预后的相互作用影响尚不清楚.
研究的目的:
- 调查代谢综合征和体重指数 (BMI) 对心血管疾病患者预后的综合影响.
- 探索年龄和性别是否影响代谢状态,BMI和心力衰竭结果之间的关系.
主要方法:
- 4,955名CHF患者被分为四种表型:代谢健康的正常体重 (MHNW),代谢不健康的正常体重 (MUNW),代谢健康的超重/肥胖 (MHO) 和代谢不健康的超重/肥胖 (MUO).
- 代谢状态是由代谢综合征 (MetS) 的存在决定的,BMI类别是正常体重 (<24 kg/m2),超重/肥胖 (≥24 kg/m2).
- 记录和分析了所有原因和心血管 (CV) 死亡的发生率,使用Cox比例风险模型.
主要成果:
- 与MHNW相比,MUNW和MUO表型显示所有原因死亡风险增加 (aHR分别为1.66和1.42).
- 在MHO表型中,所有死因死亡风险降低 (aHR为0.61).
- 这些关联主要在男性和老年女性 (≥60岁) 中观察到;然而,在非老年女性 (<60岁) 中,不论代谢状态如何,超重/肥胖都会给予保护.
结论:
- 在男性和老年女性CHF患者中,代谢综合征的不良影响超过了超重/肥胖的好处.
- 在非老年女性中,超重/肥胖对不良CHF结局提供了显著的保护,超过了代谢综合征的影响.
- 代谢健康,体重状况和CHF预后之间的相互作用取决于性别和年龄.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Obesity
392
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
392
Heart Failure I: Introduction
2
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2
Heart Failure IV: Classification and Diagnostic Evaluation
2
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
2
Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3


